Search

Your search keyword '"WELLER, Karsten"' showing total 498 results
Start Over Author "WELLER, Karsten"
498 results on '"WELLER, Karsten"'

1. Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry

Author

Pyatilova, Polina, Hackler, Yana, Aulenbacher, Felix, Asero, Riccardo, Bauer, Andrea, Bizjak, Mojca, Day, Cascia, Dissemond, Joachim, Du-Thanh, Aurélie, Fomina, Daria, Giménez-Arnau, Ana M., Grattan, Clive, Gregoriou, Stamatis, Hawro, Tomasz, Kasperska-Zajac, Alicja, Khoshkhui, Maryam, Kocatürk, Emek, Kovalkova, Elena, Kulthanan, Kanokvalai, Kuznetsova, Elizaveta, Makris, Michael, Mukhina, Olga, Pesqué, David, Peter, Jonny, Salameh, Pascale, Siebenhaar, Frank, Sikora, Agnieszka, Staubach, Petra, Tuchinda, Papapit, Zamłyński, Mateusz, Weller, Karsten, Maurer, Marcus, and Kolkhir, Pavel

Published
2024
Full Text
View/download PDF

2. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema

Author

Petersen, Remy S., Fijen, Lauré M., Apfelbacher, Christian, Magerl, Markus, Weller, Karsten, Aberer, Werner, Adatia, Adil, Audhya, Paul, Bara, Noémi-Anna, Betschel, Stephen, Boccon-Gibod, Isabelle, Bouillet, Laurence, Brodszki, Nicholas, Busse, Paula J., Buttgereit, Thomas, Bygum, Anette, Cancian, Mauro, Craig, Timothy, Csuka, Dorottya, Farkas, Henriette, Fomina, Daria, Gil-Serrano, Johana, Gompels, Mark, Guidos Fogelbach, Guillermo, Guilarte, Mar, Hide, Michihiro, Kiani-Alikhan, Sorena, Kinaciyan, Tamar, Lenten, Annet, lleonart, Ramon, Longhurst, Hilary, Lumry, William R., Malbran, Alejandro, Malinauskiene, Laura, Matta Campos, Juan J., Mendivil, Joan, Nieto-Martinez, Sandra A., Peter, Jonathan G., Porebski, Grzegorz, Reshef, Avner, Riedl, Marc, Valerieva, Anna, Waserman, Susan, Maurer, Marcus, and Cohn, Danny M.

Published
2024
Full Text
View/download PDF

4. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

Author

Maurer, Marcus, Magerl, Markus, Betschel, Stephen, Aberer, Werner, Ansotegui, Ignacio J, Aygören-Pürsün, Emel, Banerji, Aleena, Bara, Noémi-Anna, Boccon-Gibod, Isabelle, Bork, Konrad, Bouillet, Laurence, Boysen, Henrik Balle, Brodszki, Nicholas, Busse, Paula J, Bygum, Anette, Caballero, Teresa, Cancian, Mauro, Castaldo, Anthony J, Cohn, Danny M, Csuka, Dorottya, Farkas, Henriette, Gompels, Mark, Gower, Richard, Grumach, Anete S, Guidos-Fogelbach, Guillermo, Hide, Michihiro, Kang, Hye-Ryun, Kaplan, Allen P, Katelaris, Constance H, Kiani-Alikhan, Sorena, Lei, Wei-Te, Lockey, Richard F, Longhurst, Hilary, Lumry, William, MacGinnitie, Andrew, Malbran, Alejandro, Saguer, Inmaculada Martinez, Campos, Juan José Matta, Nast, Alexander, Nguyen, Dinh, Nieto-Martinez, Sandra A, Pawankar, Ruby, Peter, Jonathan, Porebski, Grzegorz, Prior, Nieves, Reshef, Avner, Riedl, Marc, Ritchie, Bruce, Sheikh, Farrukh Rafique, Smith, William B, Spaeth, Peter J, Stobiecki, Marcin, Toubi, Elias, Varga, Lilian Agnes, Weller, Karsten, Zanichelli, Andrea, Zhi, Yuxiang, Zuraw, Bruce, and Craig, Timothy

Subjects
Prevention, Clinical Research, C1-inhibitor, DELPHI, GRADE therapy, Hereditary angioedema, diagnosis, disease control, guideline, management, prophylaxis, quality of life, recommendations, self-administration, Clinical Sciences
Abstract

Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, developed 28 recommendations, and established consensus by an online DELPHI process. The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1-inhibitor (type 1) and HAE with dysfunctional C1-inhibitor (type 2), by providing guidance on common and important clinical issues, such as: 1) How should HAE be diagnosed? 2) When should HAE patients receive prophylactic on top of on-demand treatment and what treatments should be used? 3) What are the goals of treatment? 4) Should HAE management be different for special HAE patient groups such as children or pregnant/breast feeding women? 5) How should HAE patients monitor their disease activity, impact, and control? It is also the intention of this guideline to help establish global standards for the management of HAE and to encourage and facilitate the use of recommended diagnostics and therapies for all patients.

Published
2022

7. Patients With Chronic Spontaneous Urticaria Who Have Wheals, Angioedema, or Both, Differ Demographically, Clinically, and in Response to Treatment—Results From CURE

Author

Buttgereit, Thomas, Vera, Carolina, Aulenbacher, Felix, Church, Martin K., Hawro, Tomasz, Asero, Riccardo, Bauer, Andrea, Bizjak, Mojca, Bouillet, Laurence, Dissemond, Joachim, Fomina, Daria, Giménez-Arnau, Ana M., Grattan, Clive, Gregoriou, Stamatios, Kulthanan, Kanokvalai, Kasperska-Zajac, Alicja, Kocatürk, Emek, Makris, Michael, Kolkhir, Pavel, Weller, Karsten, Magerl, Markus, and Maurer, Marcus

Published
2023
Full Text
View/download PDF

10. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results

Author

Kolkhir, Pavel, Laires, Pedro A., Salameh, Pascale, Asero, Riccardo, Bizjak, Mojca, Košnik, Mitja, Dissemond, Joachim, van Doorn, Martijn, Hawro, Tomasz, Kasperska-Zajac, Alicja, Zajac, Magdalena, Kocatürk, Emek, Peter, Jonny, Parisi, Claudio A.S., Ritchie, Carla A., Kulthanan, Kanokvalai, Tuchinda, Papapit, Fomina, Daria, Kovalkova, Elena, Khoshkhui, Maryam, Kouzegaran, Samaneh, Papapostolou, Niki, Du-Thanh, Aurélie, Kamegashira, Akiko, Meshkova, Raisa, Vitchuk, Alexander, Bauer, Andrea, Grattan, Clive, Staubach, Petra, Bouillet, Laurence, Giménez-Arnau, Ana M., Maurer, Marcus, and Weller, Karsten

Published
2023
Full Text
View/download PDF

14. Non-Skin-Related Symptoms are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results from CURE

Author

Pyatilova, Polina, primary, Hackler, Yana, additional, Aulenbacher, Felix, additional, Asero, Riccardo, additional, Bauer, Andrea, additional, Bizjak, Mojca, additional, Day, Cascia, additional, Dissemond, Joachim, additional, Du-Thanh, Aurélie, additional, Fomina, Daria, additional, Giménez-Arnau, Ana M., additional, Grattan, Clive, additional, Gregoriou, Stamatis, additional, Hawro, Tomasz, additional, Kasperska-Zajac, Alicja, additional, Khoshkhui, Maryam, additional, Kocatürk, Emek, additional, Kovalkova, Elena, additional, Kulthanan, Kanokvalai, additional, Kuznetsova, Elizaveta, additional, Makris, Michael, additional, Mukhina, Olga, additional, Pesqué, David, additional, Peter, Jonny, additional, Salameh, Pascale, additional, Siebenhaar, Frank, additional, Sikora, Agnieszka, additional, Staubach, Petra, additional, Tuchinda, Papapit, additional, Zamłyński, Mateusz, additional, Weller, Karsten, additional, Maurer, Marcus, additional, and Kolkhir, Pavel, additional

Published
2024
Full Text
View/download PDF

20. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study

Author

Cherrez-Ojeda, Ivan, Vanegas, Emanuel, Cherrez, Annia, Felix, Miguel, Weller, Karsten, Magerl, Markus, Maurer, Rasmus Robin, Mata, Valeria L., Kasperska-Zajac, Alicja, Sikora, Agnieszka, Fomina, Daria, Kovalkova, Elena, Godse, Kiran, Rao, Nimmagadda Dheeraj, Khoshkhui, Maryam, Rastgoo, Sahar, Criado, Roberta FJ., Abuzakouk, Mohamed, Grandon, Deepa, Van Doorn, Martijn B.A., Oliveira Rodrigues Valle, Solange, De Souza Lima, Eduardo Magalhães, Thomsen, Simon Francis, Ramón, German D., Matos Benavides, Edgar E., Bauer, Andrea, Giménez-Arnau, Ana M., Kocatürk, Emek, Guillet, Carole, Larco, Jose Ignacio, Zhao, Zuo-Tao, Makris, Michael, Ritchie, Carla, Xepapadaki, Paraskevi, Ensina, Luis Felipe, Cherrez, Sofia, and Maurer, Marcus

Published
2021
Full Text
View/download PDF

22. CRUSE®-An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria

Author

Neisinger, Sophia, Sousa Pinto, Bernardo, Ramanauskaite, Aiste, Bousquet, Jean, Weller, Karsten, Metz, Martin, Magerl, Markus, Kocatuerk, Emek, Cherrez-Ojeda, Ivan, Gimenez-Arnau, Ana M., Parisi, Claudio Alberto S., Altrichter, Sabine, Ensina, Luis Felipe, Bouillet, Laurence, Asero, Riccardo, Goncalo, Margarida, Guillet, Carole, Rutkowski, Krzysztof, Bernstein, Jonathan A., Hardin, Hannah, Godse, Kiran, Brzoza, Zenon, Sousa, Jose Ignacio Larco, Thomsen, Simon Francis, van Doorn, Martijn, Hide, Michihiro, Ye, Young-Min, Vanderse, Staffan, Lapina, Lasma, Peter, Jonny, Zhao, Zuotao, Han, Lianyi, Nasr, Iman, Rockmann-Helmbach, Heike, Sorensen, Jennifer Astrup, Kara, Rabia oeztas, Kurjane, Natalja, Kurchenko, Andrii I., Kaidashev, Igor, Tsaryk, Vladyslav, Stepanenko, Roman, Maurer, Marcus, Neisinger, Sophia, Sousa Pinto, Bernardo, Ramanauskaite, Aiste, Bousquet, Jean, Weller, Karsten, Metz, Martin, Magerl, Markus, Kocatuerk, Emek, Cherrez-Ojeda, Ivan, Gimenez-Arnau, Ana M., Parisi, Claudio Alberto S., Altrichter, Sabine, Ensina, Luis Felipe, Bouillet, Laurence, Asero, Riccardo, Goncalo, Margarida, Guillet, Carole, Rutkowski, Krzysztof, Bernstein, Jonathan A., Hardin, Hannah, Godse, Kiran, Brzoza, Zenon, Sousa, Jose Ignacio Larco, Thomsen, Simon Francis, van Doorn, Martijn, Hide, Michihiro, Ye, Young-Min, Vanderse, Staffan, Lapina, Lasma, Peter, Jonny, Zhao, Zuotao, Han, Lianyi, Nasr, Iman, Rockmann-Helmbach, Heike, Sorensen, Jennifer Astrup, Kara, Rabia oeztas, Kurjane, Natalja, Kurchenko, Andrii I., Kaidashev, Igor, Tsaryk, Vladyslav, Stepanenko, Roman, and Maurer, Marcus

Abstract

Background: Chronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user-friendly platform to complete patient-reported outcome measures (PROMs) on their mobile devices. CRUSE ®, the Chronic Urticaria Self Evaluation app, aims to address this unmet need. Methods: CRUSE ® was developed by an international steering committee of urticaria specialists. Priorities for the app based on recent findings in CSU were defined to allow patients to track and record their symptoms and medication use over time and send photographs. The CRUSE ® app collects patient data such as age, sex, disease onset, triggers, medication, and CSU characteristics that can be sent securely to physicians, providing real-time insights. Additionally, CRUSE ® contains PROMs to assess disease activity and control, which are individualised to patient profiles and clinical manifestations. Results: CRUSE ® was launched in Germany in March 2022 and is now available for free in 17 countries. It is adapted to the local language and displays a country-specific list of available urticaria medications. English and Ukrainian versions are available worldwide. From July 2022 to June 2023, 25,710 observations were documented by 2540 users; 72.7% were females, with a mean age of 39.6 years. At baseline, 93.7% and 51.3% of users had wheals and angioedema, respectively. Second-generation antihistamines were used in 74.0% of days. Conclusions: The initial data from CRUSE ® show the wide use and utility of effectively tracking patients' disease activity and control, paving the way for personalised CSU management.

Published
2024

23. The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study

Author

Maurer, Marcus, Weller, Karsten, Magerl, Markus, Maurer, Rasmus Robin, Vanegas, Emanuel, Felix, Miguel, Cherrez, Annia, Mata, Valeria L., Kasperska-Zajac, Alicja, Sikora, Agnieszka, Fomina, Daria, Kovalkova, Elena, Godse, Kiran, Rao, Nimmagadda Dheeraj, Khoshkhui, Maryam, Rastgoo, Sahar, Criado, Roberta Fachini Jardim, Abuzakouk, Mohamed, Grandon, Deepa, van Doorn, Martijn, Valle, Solange Olliveira Rodrigues, de Souza Lima, Eduardo Magalhães, Thomsen, Simon Francis, Ramón, German D., Matos Benavides, Edgar E., Bauer, Andrea, Giménez-Arnau, Ana Maria, Kocatürk, Emek, Guillet, Carole, Ignacio Larco, Jose, Zhao, Zuo-Tao, Makris, Michael, Ritchie, Carla, Xepapadaki, Paraskevi, Ensina, Luis Felipe, Cherrez, Sofia, and Cherrez-Ojeda, Ivan

Published
2020
Full Text
View/download PDF

25. Monitoring recurrent angioedema: Findings from the Turkish angioedema control test validation study

Author

Demir, Semra, primary, Eyice‐Karabacak, Deniz, additional, Kocatürk, Emek, additional, Ünal, Derya, additional, Toprak, İlkim Deniz, additional, Korkmaz, Pelin, additional, Aslan, Ayşe Feyza, additional, İmren, Işıl Göğem, additional, Dikicier, Bahar, additional, Kahveci, Nevzat, additional, Öztop, Nida, additional, Kara, Rabia Öztaş, additional, İşsever, Halim, additional, Maurer, Marcus, additional, Weller, Karsten, additional, and Gelincik, Aslı, additional

Published
2024
Full Text
View/download PDF

27. Urticaria Patients Are Highly Interested in Apps to Monitor Their Disease Activity and Control: A UCARE CURICT Analysis

Author

Cherrez-Ojeda, Ivan, primary, Vanegas, Emanuel, additional, Cherrez, Annia, additional, Felix, Miguel, additional, Weller, Karsten, additional, Magerl, Markus, additional, Maurer, Rasmus, additional, MATA, Valeria L, additional, Kasperska-Zając, Alicja, additional, SIKORA, Agnieszka, additional, Fomina, Daria, additional, KOVALKOVA, Elena, additional, Godse, Kiran, additional, RAO, Nimmagadda Dheeraj, additional, Khoshkhui, Maryam, additional, RASTGOO, Sahar, additional, Criado, Roberta, additional, Abuzakouk, Mohamed, additional, GRANDON, Deepa, additional, Doorn, Martijn van, additional, Valle, Solange, additional, Lima, Eduardo M. de Souza, additional, Thomsen, Simon Francis, additional, Ramón, German, additional, BENAVIDES, Edgar Matos E, additional, Bauer, Andrea, additional, Arnau, Ana Giménez, additional, Kocatürk, Emek, additional, Guillet, Carole, additional, Larco, Jose Ignacio, additional, Zhao, Zuotao, additional, Makris, Michael, additional, RITCHIE, Carla, additional, XEPAPADAKI, PARASKEVI, additional, Ensina, Luis, additional, CHERREZ, Sofia, additional, and Maurer, Marcus, additional

Published
2024
Full Text
View/download PDF

28. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria

Author

Neisinger, Sophia, primary, Sousa Pinto, Bernardo, additional, Ramanauskaite, Aiste, additional, Bousquet, Jean, additional, Weller, Karsten, additional, Metz, Martin, additional, Magerl, Markus, additional, Kocatürk, Emek, additional, Cherrez‐Ojeda, Ivan, additional, Gimenez‐Arnau, Ana M., additional, Parisi, Claudio Alberto S., additional, Altrichter, Sabine, additional, Ensina, Luis Felipe, additional, Bouillet, Laurence, additional, Asero, Riccardo, additional, Gonçalo, Margarida, additional, Guillet, Carole, additional, Rutkowski, Krzysztof, additional, Bernstein, Jonathan A., additional, Hardin, Hannah, additional, Godse, Kiran, additional, Brzoza, Zenon, additional, Sousa, Jose Ignacio Larco, additional, Thomsen, Simon Francis, additional, van Doorn, Martijn, additional, Hide, Michihiro, additional, Ye, Young‐Min, additional, Vanderse, Staffan, additional, Lapiņa, Lāsma, additional, Peter, Jonny, additional, Zhao, Zuotao, additional, Han, Lianyi, additional, Nasr, Iman, additional, Rockmann‐Helmbach, Heike, additional, Sørensen, Jennifer Astrup, additional, Kara, Rabia Öztaş, additional, Kurjāne, Natalja, additional, Kurchenko, Andrii I., additional, Kaidashev, Igor, additional, Tsaryk, Vladyslav, additional, Stepanenko, Roman, additional, and Maurer, Marcus, additional

Published
2024
Full Text
View/download PDF

38. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial

Author

Weller, Karsten, primary, Gimenez‐Arnau, Ana Maria, additional, Baron, Jens, additional, Brehler, Randolf, additional, Ferrer, Marta, additional, Groffik, Adriane, additional, Grundmann, Sonja, additional, Jakob, Thilo, additional, Labrador‐Horrillo, Moisés, additional, Müller, Sabine, additional, Staubach, Petra, additional, Wurpts, Gerda, additional, Metz, Martin, additional, and Maurer, Marcus, additional

Published
2023
Full Text
View/download PDF

41. Urticaria

Author

Maurer, Marcus, Magerl, Markus, Zuberbier, Torsten, Weller, Karsten, and Kabashima, Kenji, editor

Published
2016
Full Text
View/download PDF

44. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.

Author

Weller, Karsten, Gimenez‐Arnau, Ana Maria, Baron, Jens, Brehler, Randolf, Ferrer, Marta, Groffik, Adriane, Grundmann, Sonja, Jakob, Thilo, Labrador‐Horrillo, Moisés, Müller, Sabine, Staubach, Petra, Wurpts, Gerda, Metz, Martin, and Maurer, Marcus

Subjects
*URTICARIA, *PREVENTIVE medicine
Abstract

Background: Non‐sedating H1‐antihistamines (nsAH) are the most commonly used treatment for chronic spontaneous urticaria (CSU). Many patients use them as on‐demand (OD) therapy rather than a maintenance treatment. Here, we compared OD versus daily maintenance treatment with the nsAH rupatadine, assessed the efficacy of rupatadine updosing, and investigated potential long‐term disease‐modifying effects. Methods: This multicenter, randomized study consisted of 2 weeks of screening, 8 weeks of double‐blind treatment, and 6 weeks of treatment‐free follow‐up (OD allowed). Adult patients were randomized to 10 mg rupatadine OD or 10 mg rupatadine daily. At Week 4, if patients did not have a complete response, they switched from 10 to 20 mg rupatadine daily or underwent sham updosing (patients on 10 mg rupatadine OD). The primary aim was to compare CSU disease activity at the end of follow‐up between daily versus OD. Additionally, we assessed the efficacy of rupatadine updosing. Major outcomes were disease activity, CSU‐related quality of life (QoL), and disease control. Results: At Week 4, disease activity and QoL significantly improved in daily versus OD‐treated patients. Updosing of rupatadine did not improve the mean disease activity, but the number of complete responders increased during updosing from 5% to 22%. At the end of follow‐up, the disease activity of patients treated OD versus daily was not significantly different. Conclusions: Daily rupatadine treatment significantly improved CSU disease activity and QoL during treatment versus OD treatment but not after discontinuation of rupatadine, indicating the benefits of a daily maintenance nsAH schedule. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

45. Urticaria Control Test real‐world performance: A post‐hoc analysis.

Author

Salameh, Pascale, Gutsche, Annika, Aulenbacher, Felix, Buttgereit, Thomas, Weller, Karsten, Siebenhaar, Frank, and Maurer, Marcus

Subjects
URTICARIA, CHRONIC diseases, PREVENTIVE medicine, TEST validity
Abstract

This article discusses the Urticaria Control Test (UCT), a patient-reported outcome measure used to assess disease control in chronic urticaria (CU). The study aimed to validate the UCT in a real-world population by analyzing data from 1357 CU patients. The results showed that all four questions of the UCT are relevant in measuring disease control, and no question could be omitted without affecting the construct validity. The authors suggest that the four-question approach should be retained, but further studies are needed to confirm these findings in different populations and languages. [Extracted from the article]

Published
2024
Full Text
View/download PDF

46. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria.

Author

Neisinger, Sophia, Sousa Pinto, Bernardo, Ramanauskaite, Aiste, Bousquet, Jean, Weller, Karsten, Metz, Martin, Magerl, Markus, Kocatürk, Emek, Cherrez‐Ojeda, Ivan, Gimenez‐Arnau, Ana M., Parisi, Claudio Alberto S., Altrichter, Sabine, Ensina, Luis Felipe, Bouillet, Laurence, Asero, Riccardo, Gonçalo, Margarida, Guillet, Carole, Rutkowski, Krzysztof, Bernstein, Jonathan A., and Hardin, Hannah

Subjects
PATIENT monitoring, URTICARIA, PATIENT reported outcome measures, SELF-evaluation, SYMPTOMS
Abstract

Background: Chronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user‐friendly platform to complete patient‐reported outcome measures (PROMs) on their mobile devices. CRUSE®, the Chronic Urticaria Self Evaluation app, aims to address this unmet need. Methods: CRUSE® was developed by an international steering committee of urticaria specialists. Priorities for the app based on recent findings in CSU were defined to allow patients to track and record their symptoms and medication use over time and send photographs. The CRUSE® app collects patient data such as age, sex, disease onset, triggers, medication, and CSU characteristics that can be sent securely to physicians, providing real‐time insights. Additionally, CRUSE® contains PROMs to assess disease activity and control, which are individualised to patient profiles and clinical manifestations. Results: CRUSE® was launched in Germany in March 2022 and is now available for free in 17 countries. It is adapted to the local language and displays a country‐specific list of available urticaria medications. English and Ukrainian versions are available worldwide. From July 2022 to June 2023, 25,710 observations were documented by 2540 users; 72.7% were females, with a mean age of 39.6 years. At baseline, 93.7% and 51.3% of users had wheals and angioedema, respectively. Second‐generation antihistamines were used in 74.0% of days. Conclusions: The initial data from CRUSE® show the wide use and utility of effectively tracking patients' disease activity and control, paving the way for personalised CSU management. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

47. CRUSE – What the first 100 days have taught us

Author

Neisinger, Sophia, primary, Pinto, Bernardo Sousa, additional, Ramanauskaite, Aiste, additional, Bousquet, Jean, additional, Weller, Karsten, additional, Metz, Martin, additional, Magerl, Markus, additional, Kocatürk, Emek, additional, Ojeda, Ivan Cherrez, additional, Gimenez-Arnau, Ana M, additional, and Maurer, Marcus, additional

Published
2023
Full Text
View/download PDF

50. Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 Individuals

Author

Basmanav, F Buket, Cesarato, Nicole, Kumar, Sheetal, Borisov, Oleg, Kokordelis, Pavlos, Ralser, Damian J, Wehner, Maria, Axt, Daisy, Xiong, Xing, Thiele, Holger, Dolgin, Vadim, Gossmann, Yasmina, Fricker, Nadine, Dewenter, Malin Katharina, Weller, Karsten, Suri, Mohnish, Reichenbach, Herbert, Oji, Vinzenz, Addor, Marie-Claude, Ramirez, Karla, Stewart, Helen, Garcia Bartels, Natalie, Weibel, Lisa, Wagner, Nicola, George, Susannah, Kilic, Arzu, Tantcheva-Poór, Iliana, Stewart, Alison, Dikow, Nicola, Blaumeiser, Bettina, et al, and University of Zurich

Subjects
2708 Dermatology, 610 Medicine & health, 10220 Clinic for Surgery
Published
2022

Catalog

Books, media, physical & digital resources
See catalog results